RA
ENOV icon

Royce & Associates’s Enovis ENOV Stock Holding History

Royce & Associates’s Portfolio ENOV Stock Details ENOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.9M Sell
611,090
-215,758
-26% -$5.1M 0.14% 242
2025
Q4 		$22M Buy
826,848
+105,608
+15% +$3.12M 0.22% 137
2025
Q3 		$21.9M Sell
721,240
-1,697,683
-70% -$51.5M 0.22% 150
2025
Q2 		$75.9M Sell
2,418,923
-71,883
-3% -$2.38M 0.78% 9
2025
Q1 		$95.2M Buy
2,490,806
+20,230
+0.8% +$858K 1.03% 4
2024
Q4 		$108M Buy
2,470,576
+66,891
+3% +$2.94M 1.01% 4
2024
Q3 		$103M Buy
2,403,685
+346,317
+17% +$15.4M 0.94% 3
2024
Q2 		$93M Buy
2,057,368
+457,308
+29% +$23.7M 0.87% 8
2024
Q1 		$99.9M Buy
1,600,060
+6,605
+0.4% +$395K 0.89% 8
2023
Q4 		$89.3M Buy
1,593,455
+240,480
+18% +$12M 0.82% 10
2023
Q3 		$71.3M Buy
1,352,975
+243,278
+22% +$14.2M 0.73% 14
2023
Q2 		$71.2M Sell
1,109,697
-5,290
-0.5% -$301K 0.69% 17
2023
Q1 		$59.6M Sell
1,114,987
-2,034
-0.2% -$118K 0.6% 24
2022
Q4 		$59.8M Buy
1,117,021
+127,794
+13% +$6.6M 0.63% 26
2022
Q3 		$45.6M Buy
989,227
+363,928
+58% +$19.7M 0.52% 34
2022
Q2 		$34.4M Sell
625,299
-253,172
-29% -$16.3M 0.35% 61
2022
Q1 		$60.2M Buy
878,471
+23,434
+3% +$1.67M 0.51% 34
2021
Q4 		$67.7M Sell
855,037
-75,758
-8% -$6.34M 0.51% 35
2021
Q3 		$73.5M Sell
930,795
-111,528
-11% -$8.96M 0.55% 22
2021
Q2 		$82.2M Sell
1,042,323
-191,876
-16% -$14.7M 0.56% 18
2021
Q1 		$93.1M Sell
1,234,199
-325,978
-21% -$23.9M 0.63% 12
2020
Q4 		$103M Buy
1,560,177
+6,770
+0.4% +$396K 0.85% 3
2020
Q3 		$83.8M Sell
1,553,407
-37,791
-2% -$2.08M 0.9% 3
2020
Q2 		$76.4M Buy
1,591,198
+32,181
+2% +$1.42M 0.84% 4
2020
Q1 		$53.1M Buy
1,559,017
+86,902
+6% +$4.78M 0.72% 19
2019
Q4 		$92.2M Buy
1,472,115
+79,284
+6% +$4.48M 0.82% 10
2019
Q3 		$69.7M Buy
1,392,831
+174,779
+14% +$8.25M 0.64% 25
2019
Q2 		$58.8M Buy
1,218,052
+157,768
+15% +$7.6M 0.53% 38
2019
Q1 		$54.2M Buy
1,060,284
+859,138
+427% +$37.7M 0.46% 49
2018
Q4 		$7.24M Buy
201,146
+85,511
+74% +$3.99M 0.06% 419
2018
Q3 		$7.18M Buy
115,635
+29,050
+34% +$1.66M 0.05% 490
2018
Q2 		$4.57M Hold
86,585
– – 0.03% 615
2018
Q1 		$4.75M Hold
86,585
– – 0.03% 584
2017
Q4 		$5.9M Sell
86,585
-1,602
-2% -$108K 0.04% 537
2017
Q3 		$6.32M Hold
88,187
– – 0.04% 515
2017
Q2 		$5.98M Hold
88,187
– – 0.04% 535
2017
Q1 		$5.96M Hold
88,187
– – 0.04% 528
2016
Q4 		$5.45M Hold
88,187
– – 0.04% 550
2016
Q3 		$4.77M Hold
88,187
– – 0.03% 603
2016
Q2 		$4.02M Hold
88,187
– – 0.03% 650
2016
Q1 		$4.34M Buy
88,187
+16,317
+23% +$694K 0.03% 649
2015
Q4 		$2.89M Buy
71,870
+38,753
+117% +$1.78M 0.02% 774
2015
Q3 		$1.71M Buy
+33,117
New +$2.2M 0.01% 894

Other funds holding ENOV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Royce & Associates's ENOV Position: Q1 2026 in Review

Royce & Associates reduced its Enovis (ENOV) stake by 26% in Q1 2026, selling an estimated $5.1M and leaving 611,090 shares worth $13.9M. The position accounts for 0.14% of the portfolio, ranked #242.

Royce & Associates first reported a position in ENOV in Q3 2015 and has held it in 43 quarters since. The position peaked at $108M in Q4 2024. 254 funds tracked by Wall St. Rank hold ENOV as of Q1 2026.

  • Royce & Associates held 611,090 shares of Enovis worth $13.9M as of Q1 2026.
  • Royce & Associates sold 215,758 Enovis shares in Q1 2026, an estimated $5.1M.
  • Enovis made up 0.14% of Royce & Associates's portfolio in Q1 2026, its #242 holding.
  • Royce & Associates first reported a position in Enovis in Q3 2015 and has held it in 43 quarters since.
  • Royce & Associates's Enovis position peaked at $108M in Q4 2024.
  • 254 funds tracked by Wall St. Rank held Enovis as of Q1 2026.

Based on Royce & Associates's 13F filing for Q1 2026, filed 12 May 2026.